why is compounded tirzepatide still being sold FDA ban on tirzepatide: Switch to name brand medications Buy Tirzepatide for Weight Loss

The most prevalent gastrointestinal adverse effects include: Nausea (37-43% of patients, the most common side effect) Diarrhea (24-30% of patients) Vomiting (19-25% of patients) Constipation (17-24% of patients) Abdominal pain (11-20% of patients) Dyspepsia or indigestion (10-11% of patients) Decreased appetite (reported as a separate effect) It's important to note that while some patients experience increased bowel movements or diarrhea, others develop constipationhighlighting the variable nature of tirzepatide's effects on individual digestive systems

The pricing-pressure narrative overstates the near-term IRA impact

10.3390/jpm12030454 55 RosenthalR

This can be attributed to the medications multifaceted mechanism of action, which not only helps regulate blood sugar but also promotes satiety and facilitates weight loss

M., & Bloom, J